Bioliberty, a medtech company headquartered in Edinburgh and Boston, has secured $10.2 million in funding to further develop its rehabilitation technology and expand into the U.S. market.
Bioliberty, a medtech company headquartered in Edinburgh and Boston, has secured $10.2 million in funding to further develop its rehabilitation technology and expand into the U.S. market.
Dundee-based aquaculture technology company Ace Aquatec has raised £10 million (approx. €11.7 million) to scale its welfare-first fish farming solutions.
Glasgow-based Solasta Bio, an agri-biotech company specializing in green insecticides, has raised €12.6 million in an oversubscribed Series A funding round. The round was led by Forbion’s BioEconomy fund, with co-leads FMC Ventures and Corteva Inc., and participation from existing investors such as Cavallo Ventures, Scottish Enterprise, and the University
Edinburgh-based Administrate, a cloud-based training management platform, has successfully raised €3.5 million (£3M) in funding from the Investment Fund for Scotland (IFS). This investment, managed by Maven and delivered by the British Business Bank, will enable Administrate to launch its new AI-powered scheduling software and expand its market reach to
EnteroBiotix, a Glasgow-based biotech firm specializing in microbiome therapeutics, has successfully closed a funding round totaling £27M (approximately €31.46M). This round combines £15.7M (approximately €18.29M) in fresh equity with the conversion of £11.6M (approximately €13.51M) of loan notes into equity.
Bevvy, a Scotland-based whisky discovery platform, has successfully raised $1.5 million in seed investment. This funding, contributed by Scottish angel investors, existing shareholders, and a US-based family office, will be used to consolidate Bevvy's market share and expand its consumer audience into new territories, including the United States.
